Newsfeeds - Spark Newswire

5 minute read

Vir Biotechnology To Present Clinical Data From Ongoing Trials Of VIR-2218 Qnd VIR-3434 in Patients With Chronic Hepatitis B Virus Infection At The International Liver Congress 2021

Today, 12:42 PM

– Results demonstrate positive safety profiles and a reduction in HBsAg for two novel HBV therapies administrated as monotherapy or in combination with other agents – – Management to host

VIR

5 minute read

The Daily Biotech Pulse: Roche Gets Authorization For COVID-19 Treatment, Nods For Sanofi-Regeneron In Europe, Osmotica Divestment, 2 IPOs

By Shanthi Rexaline

Today, 12:42 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 24)

ABBV

4 minute read

The Daily Biotech Pulse: Gemini Sinks On Data, Amgen’s Migraine Drug Approved In Japan, Liver Congress Gets Underway

By Shanthi Rexaline

Today, 12:42 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 22)

ACET

1 minute read

Dual-Antibody Cocktail Shows Effectiveness In COVID-19 Animal Models: Reuters

By Vandana Singh

Today, 12:42 PM

In mice and hamster study, COVID-19 therapies comprising two types of antibodies were found to be effective against…

ABBV

1 minute read

GSK – Vir Biotech’s Sotrovimab Reduces Hospitalization, Risk Of Death In Adult COVID-19 Patients

By Vandana Singh

Today, 12:42 PM

GlaxoSmithKline plc (NYSE:GSK) and Vir Biotechnology Inc (NASDAQ:VIR) have announced final, confirmatory results from the Phase 3 COMET-ICE evaluating sotrovimab in high-risk adult…

GSK

1 minute read

News

GSK and Vir Biotechnology Announce Continuing Progress of the COMET Clinical Development Program for Sotrovimab

By Benzinga Newsdesk

Today, 12:42 PM

– Analysis of final Day 29 data from COMET-ICE confirms sotrovimab significantly reduces hospitalization and risk of death in adults with mild-to-moderate COVID-19 who are at high risk of progression to

GSK

5 minute read

The Week Ahead In Biotech: Incyte, Ascendis FDA Decisions, Liver Congress Presentations And 4 IPOs

By Shanthi Rexaline

Today, 12:42 PM

Biotech stocks came under pressure in the week ended June 18, dragged by the negative sentiment that prevailed in the broader market due to macroeconomic worries.

ABBV

1 minute read

Kuwait Approved Sotrovimab Treatment For COVID-19

By Benzinga Newsdesk

Today, 12:42 PM

-Reuters Citing State Media

GSK

1 minute read

Uncategorized

GlaxoSmithKline – Vir Biotech’s Antibody COVID-19 Treatment Wins CHMP’s Positive Scientific Opinion

By Vandana Singh

Today, 12:42 PM

The European Medicines Agency’s advisory group, Committee for Human Medicinal Products (CHMP), has concluded that GlaxoSmithKline plc (NYSE: GSK) and Vir…

GSK

1 minute read

Uncategorized

EMA Says Concluded Sotrovimab Can Be Used To Treat COVID-19 In Adults And Adolescents Not Requiring Supplemental Oxygen Therapy And Risk Of Progressing To Severe COVID-19; Says A Rolling Review Of Sotrovimab, Which Started On 7 May, Is Ongoing

By Bill Haddad

Today, 12:42 PM

-Reuters

GSK